Challenges for Cardiovascular Drug Research

Challenges for treatment of cardiovascular diseases based on stem cells

Introduction: Cardiovascular diseases (CVD) are the primary cause of death worldwide, and the development of scar tissue in myocardium and also the irreversible destruction of cardiomyocytes are the main factors in their development. There are still limitations in medical treatment of CVD, despite the advances in the field of drug therapy and surgery for CVD. In recent years, research on stem c...

Clinical and research challenges in risk factors for cardiovascular diseases.

The European Society of Cardiology has a comparable organization in the U.S.A. in the American Heart Association, whose first president was Dr Lewis Atterbury Conner. Dr Connor was also the founding editor of the American Heart Journal. His contributions in the early 20th century were as significant as those of any single individual in focusing concerns about the emerging importance of cardiova...

RAMADAN AND CARDIOVASCULAR DRUG USE

The Grand Challenges in Cardiovascular Drug Discovery and Development

Despite the major advancements in cardiovascular medicine over the past 50 years, heart disease and stroke remain the number one public health concern and primary causes of death today. The development of effective medicines that control blood pressure and cholesterol has significantly cut deaths from heart disease. According to a 2008 report, death rates for cardiovascular disease fell a remar...

Clinical research challenges in the era of cardiovascular medical devices

New therapeutic alternatives, such as innovative medical devices, are frequently the only treatment options left for patients when other efficient medical modalities are lacking or insufficient. Development of novel devices, which are safe and effective, requires understanding of complex premarket and postmarket provisions, including characteristics of clinical trials. Speeding up patient acces...